Methionine Sulfoximine May Improve Inflammation in Autism, A Novel Hypothesized Treatment for Autism

Archives of Medical Research

Volumn 41, Issue 8, 2010, Pages 651-652

  Ghanizadeh, Ahmad ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; GLUTAMIC ACID; INTERLEUKIN 1BETA; MEMANTINE; METHIONINE SULFOXIMINE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; VERY LONG CHAIN FATTY ACID;

ARTICLE; ASTROCYTE; AUTISM; CELL ACTIVATION; DISEASE MODEL; FATTY ACID METABOLISM; FATTY ACID OXIDATION; HUMAN; INFLAMMATION; MICROGLIA; NEUROTOXICITY; NONHUMAN;

ANIMALS; AUTISTIC DISORDER; EXCITATORY AMINO ACID ANTAGONISTS; FATTY ACIDS; GLUTAMIC ACID; HUMANS; INFLAMMATION; METHIONINE SULFOXIMINE;

EID: 78650719460     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2010.10.012     Document Type: Article

References (17)

1. MacFabe D.F., Cain D.P., Rodriguez-Capote K., et al. Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav Brain Res 2007, 10(176):149-169.
2. Minshew N.J., Goldstein G., Dombrowski S.M., et al. A preliminary 31P MRS study of autism: evidence for undersynthesis and increased degradation of brain membranes. Biol Psychiatry 1993, 33:762-773.
3. Horrobin D.F. A possible role for phospholipases in autism and Asperger's syndrome. Phospholipid Spectrum Disorder in Psychiatry 1999, Carnforth: Marius Press. M. Peet, I. Glen, D.F. Horrobin (Eds.).
4. Pastural E., Ritchie S., Lu Y., et al. Novel plasma phospholipid biomarkers of autism: mitochondrial dysfunction as a putative causative mechanism. Prostaglandins Leukot Essent Fatty Acids 2009, 81:253-264.
5. Ramoz N., Reichert J.G., Smith C.J., et al. Linkage and association of the mitochondrial aspartate/glutamate carrier SLC25A12 gene with autism. Am J Psychiatry 2004, 161:662-669.
6. Blaylock R.L., Strunecka A. Immune-glutamatergic dysfunction as a central mechanism of the autism spectrum disorders. Curr Med Chem 2009, 16:157-170.
7. Niederhofer H. Glutamate antagonists seem to be slightly effective in psychopharmacologic treatment of autism. J Clin Psychopharmacol 2007, 27:317-318.
8. Chez M.G., Burton Q., Dowling T., et al. Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: an observation of initial clinical response and maintenance tolerability. J Child Neurol 2007, 22:574-579.
9. Segurado R., Conroy J., Meally E., et al. Confirmation of association between autism and the mitochondrial aspartate/glutamate carrier SLC25A12 gene on chromosome 2q31. Am J Psychiatry 2005, 162:2182-2184.
10. Maezawa I., Jin L.W. Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate. J Neurosci 2010, 30:5346-5356.
11. Li X., Chauhan A., Sheikh A.M., et al. Elevated immune response in the brain of autistic patients. J Neuroimmunol 2009, 207:111-116.
12. Krause J.E., Chirgwin J.M., Carter M.S., et al. Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A. Proc Natl Acad Sci USA 1987, 84:881-885.
13. Venters H.D., Dantzer R., Kelley K.W. A new concept in neurodegeneration: TNFalpha is a silencer of survival signals. Trends Neurosci 2000, 23:175-180.
14. Tikka T., Fiebich B.L., Goldsteins G., et al. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 2001, 15:2580-2588.
15. Chaparro-Huerta V., Rivera-Cervantes M.C., Flores-Soto M.E., et al. Proinflammatory cytokines and apoptosis following glutamate-induced excitotoxicity mediated by p38 MAPK in the hippocampus of neonatal rats. J Neuroimmunology 2005, 165:53-62.
16. Allan S.M., Tyrrell P.J., Rothwell N.J. Interleukin-1 and neuronal injury. Nat Rev Immunol 2005, 5:629-640.
17. Ghoddoussi F., Galloway M.P., Jambekar A., et al. Methionine sulfoximine, an inhibitor of glutamine synthetase, lowers brain glutamine and glutamate in a mouse model of ALS. J Neurol Sci 2010, 290:41-47.